aTYR PHARMA INC
Develops medicines based on tRNA synthetase biology for fibrosis and inflammation.
ATYR | US
Overview
Corporate Details
- ISIN(s):
- US0021202025
- LEI:
- Country:
- United States of America
- Address:
- 10240 SORRENTO VALLEY ROAD, 92121 SAN DIEGO
- Website:
- https://www.atyrpharma.com/
- Sector:
- Manufacturing
Description
aTyr Pharma is a clinical-stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. The company focuses on translating transfer RNA (tRNA) synthetase biology into potential first-in-class therapies. Its primary therapeutic areas of interest are fibrosis and inflammation. aTyr Pharma's lead clinical candidate, efzofitimod (ATYR1923), is being developed for the treatment of pulmonary sarcoidosis and other interstitial lung diseases. The company utilizes its proprietary platform to research the extracellular functionality and signaling pathways of tRNA synthetases to create new product candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all aTYR PHARMA INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for aTYR PHARMA INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for aTYR PHARMA INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
